Skin cancer is the most common cancer in the U.S., with risks influenced by factors like sun exposure, skin type, and income.

A Wakefield woman who survived cancer will host a showbusiness gala in the city to raise money for the charities that helped ...

Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...

Squamous cell carcinoma is the second most common type of skin cancer, and can be deadly if left untreated. Here are the ...

A patient shares his experience with a squamous cell carcinoma diagnosis, treatment and recovery. It was a Friday afternoon, ...

When diagnosing lung metastases and second primary lung cancer in patients with head and neck cancer, low-dose CT leads to better sensitivity than chest x-ray but does not lead to improved overall ...

Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Phase 1/2 trial evaluating the proprietary combination to be run under CRADA with the National Cancer InstituteSecondVersamune®platform candidate ...

Researchers are investigating whether a common cholesterol drug could be repurposed to treat HPV-positive cervical cancer.

Head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy ...